One Stop Solution For In-Depth Market Research Reports

詳細な市場調査レポートのワンストップソリューション

Home    >    HEALTHCARE AND PHARMACEUTICALS   >   Veterinary Pain Management Market

獣医の痛みの管理市場ー業界洞察、主要プレーヤー・企業別、成長機会別、最新傾向別、開発別、主要な成長ドライバー別、主要な課題別によってセグメンテーション、予測 2023年


[ 英語タイトル ] Veterinary Pain Management Market by Product (Drugs (NSAIDs, Opioids), Device (Laser, Electromagnetic)), Application (Osteoarthritis, Cancer), Animal Type (Dog, Cat, Horse, Cattle), Distribution Channel (Hospital, Pharmacy) - Global Forecast to 2023


Product Code : MNMHC00109682
Survey : MarketsandMarkets
Publish On : May, 2021
Category : Healthcare and Pharmaceuticals
Study Area : Global
Report format : PDF
Sales price option (consumption tax not included)
Single User USD5650 / Question Form
5 User USD6650 / Question Form
Enterprise User USD10000 / Question Form

[Report Description]

“Global veterinary pain management market projected to grow at a CAGR of 8.0%”
The global veterinary pain management market is projected to reach USD 1.66 billion by 2023 from USD 1.13 billion in 2018, at a CAGR of 8.0% during the forecast period. Factors such as growth in companion animal adoption, increasing number of veterinary practitioners and their rising income levels in developed economies, growing prevalence of animal diseases causing pain and inflammation, and rising adoption of pet insurance with growing animal health expenditure are expected to drive the growth of the market. However, increasing pet care cost may restrain market growth to a certain extent.
“By devices, laser therapy devices held the largest market share in 2017”
On the basis of devices, the market is segmented into laser and electromagnetic therapy devices. Laser therapy devices accounted for the largest share of the veterinary pain management devices market. The large share of this segment can be attributed to the effectiveness of laser therapy devices in curing a wide range of acute and chronic pain conditions in animals.
“By application, the cancer segment is expected to grow at the highest CAGR during the forecast period”
On the basis of application, the market is segmented into joint pain, postoperative pain, cancer, and other applications. The cancer segment is expected to grow at the highest CAGR during the forecast period. This can be attributed to the growing prevalence of cancer in companion animals and the requirement of pain management at every stage of cancer treatment.
“By animal type, the companion animal held the largest market share in 2017”
By animal type, the market is further segmented into companion and livestock. In 2017, the companion animals segmented accounted for the largest share of the veterinary pain management market due to increasing companion animal ownership, growing awareness about animal health among pet owners, and rising pet healthcare expenditure.
“North America is expected to grow at the largest share during the forecast period (2018-2023)”
North America dominated the veterinary pain management market in 2017, followed by Europe, Asia Pacific, Latin America, and the Middle East & Africa. In North America, the US is expected to hold the largest share of the veterinary pain management market due to the growing number of people adopting pets, increasing animal healthcare expenditure, growing veterinary practices, and increasing prevalence of chronic diseases such as cancer and osteoarthritis.
Break of primary participants was as mentioned below:
• By Company Type – Tier 1–45%, Tier 2–30% and Tier 3–25%
• By Designation – C-level–45%, Director Level–32%, Others–23%
• By Region – North America–46%, Europe–27%, Asia-Pacific–20%, Latin America–4%, Middle East & Africa- 3%

The major players in the veterinary pain management market are Zoetis(US), Merck Animal Health (US), Elanco (US), Chanelle (Ireland), Boehringer Ingelheim (Germany), Vetoquinol (France), Bayer (Germany), Norbrook (Ireland), Ceva Santé Animale (France), K-Laser (US), Assisi (US), and Dechra Pharmaceuticals (UK).
Research Coverage:
The veterinary pain management market in this report is segmented by product, application, animal type, distribution channel, and regions. It provides detailed information regarding major factors influencing the growth market (drivers, restraints, opportunities, and industry-specific challenges). The study tracks and analyzes competitive developments (such as partnerships, agreements, collaborations, mergers & acquisitions, new product developments, geographical expansions, and R&D activities) and strategically profiles the key players and comprehensively analyzes their market shares and core competencies in the veterinary pain management market.
Reasons to buy this report:
From an insight perspective, this research report has focused on various levels of analysis—market share analysis of top players, company profiles which together comprise and discuss the basic views on the competitive landscape; emerging and high-growth segments of the veterinary pain management market; high-growth regions; and market drivers, restraints, and opportunities. The report provides the latest veterinary pain industry statistics and industry trends, allowing buyers to identify the high growth product segment and potential customers and suppliers hence driving revenue growth and profitability.

The report provides insights on the following pointers:
• Market Penetration: Comprehensive information on pain management products offered by the top players in the global veterinary pain management market

• Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product launches in the veterinary pain management market

• Market Development: Comprehensive information about lucrative emerging markets – the report analyzes the markets for veterinary pain management market across regions

• Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the global veterinary pain management market

• Competitive Assessment: In-depth assessment of market shares, strategies, products, and manufacturing capabilities of the leading players in the global veterinary pain management market

TABLE OF CONTENTS

1 INTRODUCTION 20
1.1 OBJECTIVES OF THE STUDY 20
1.2 MARKET DEFINITION 20
1.3 MARKET SCOPE 20
1.3.1 MARKETS COVERED 21
1.3.2 YEARS CONSIDERED FOR THE STUDY 22
1.4 CURRENCY 22
1.5 STAKEHOLDERS 23
2 RESEARCH METHODOLOGY 24
2.1 RESEARCH DATA 24
2.1.1 SECONDARY SOURCES 25
2.1.1.1 Key data from secondary sources 26
2.1.2 PRIMARY SOURCES 26
2.1.2.1 Key data from primary sources 27
2.1.2.2 Key industry insights 28
2.2 MARKET SIZE ESTIMATION 29
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION 31
2.4 MARKET SHARE ESTIMATION 32
2.5 ASSUMPTIONS FOR THE STUDY 32
2.6 LIMITATIONS 32
3 EXECUTIVE SUMMARY 33
4 PREMIUM INSIGHTS 39
4.1 VETERINARY PAIN MANAGEMENT: MARKET OVERVIEW 39
4.2 ASIA PACIFIC: VETERINARY PAIN MANAGEMENT MARKET, BY APPLICATION 40
4.3 GEOGRAPHIC SNAPSHOT OF THE VETERINARY PAIN MANAGEMENT MARKET 41
4.4 VETERINARY PAIN MANAGEMENT MARKET: DEVELOPING VS. DEVELOPED COUNTRIES/REGIONS 42
4.5 VETERINARY PAIN MANAGEMENT MARKET: REGIONAL MIX 42
5 MARKET OVERVIEW 43
5.1 INTRODUCTION 43
5.2 MARKET DYNAMICS 43
5.2.1 DRIVERS 44
5.2.1.1 Growth in companion animal adoption 44
5.2.1.2 Growth in the number of veterinary practitioners and their income levels in developed economies 44
5.2.1.3 Growing prevalence of animal diseases causing pain and inflammation 45
5.2.1.4 Rising demand for pet insurance with growing animal health expenditure 46
5.2.2 RESTRAINT 47
5.2.2.1 Increasing pet care costs 47
5.2.3 OPPORTUNITIES 47
5.2.3.1 Increasing popularity of non-conventional and non-pharmaceutical treatment techniques 47
5.2.3.2 Untapped emerging markets 48
5.2.4 CHALLENGES 48
5.2.4.1 Low animal healthcare awareness in emerging markets 48
5.2.4.2 Stringent regulatory approval process for pain management drugs 48
5.3 REGULATORY ANALYSIS 49
6 VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT 53
6.1 INTRODUCTION 54
6.2 DRUGS 55
6.2.1 DRUGS, BY TYPE 55
6.2.1.1 NSAIDs 56
6.2.1.2 Opioids 57
6.2.1.3 Local Anesthetics 59
6.2.1.4 Alpha-2 Agonists 60
6.2.1.5 Disease-modifying Osteoarthritis Drugs (DMOADs) 61
6.2.1.6 Other Drugs 62
6.2.2 DRUGS, BY ROUTE OF ADMINISTRATION 63
6.2.2.1 Oral 64
6.2.2.2 Parenteral 65
6.2.2.3 Topical 66
6.3 DEVICES 68
6.3.1 LASER THERAPY DEVICES 68
6.3.2 ELECTROMAGNETIC THERAPY DEVICES 69
7 VETERINARY PAIN MANAGEMENT MARKET, BY APPLICATION 71
7.1 INTRODUCTION 72
7.2 JOINT PAIN 73
7.2.1 OSTEOARTHRITIS 73
7.2.2 MUSCULOSKELETAL DISORDERS 74
7.3 POSTOPERATIVE PAIN 76
7.4 CANCER 77
7.5 OTHER APPLICATIONS 78

8 VETERINARY PAIN MANAGEMENT MARKET, BY ANIMAL TYPE 80
8.1 INTRODUCTION 81
8.2 COMPANION ANIMALS 82
8.2.1 DOGS 83
8.2.2 CATS 86
8.2.3 HORSES 87
8.2.4 OTHER COMPANION ANIMALS 89
8.3 LIVESTOCK 90
8.3.1 CATTLE 92
8.3.2 SWINE 93
8.3.3 OTHER LIVESTOCK 95
9 VETERINARY PAIN MANAGEMENT MARKET, BY DISTRIBUTION CHANNEL 96
9.1 INTRODUCTION 97
9.2 VETERINARY HOSPITALS & CLINICS 98
9.3 PHARMACY 100
10 VETERINARY PAIN MANAGEMENT MARKET, BY REGION 101
10.1 INTRODUCTION 102
10.2 NORTH AMERICA 103
10.2.1 US 109
10.2.2 CANADA 113
10.3 EUROPE 119
10.3.1 GERMANY 125
10.3.2 UK 130
10.3.3 FRANCE 135
10.3.4 ITALY 140
10.3.5 SPAIN 145
10.3.6 REST OF EUROPE (ROE) 149
10.4 ASIA PACIFIC 155
10.4.1 CHINA 161
10.4.2 JAPAN 166
10.4.3 INDIA 171
10.4.4 REST OF ASIA PACIFIC (REST OF APAC) 175
10.5 LATIN AMERICA 181
10.6 MIDDLE EAST AND AFRICA 186
11 COMPETITIVE LANDSCAPE 192
11.1 OVERVIEW 192
11.2 PRODUCT PORTFOLIO MIX 193
11.3 GROWTH STRATEGY MATRIX 193
11.4 MARKET SHARE ANALYSIS, 2017 194
11.5 COMPETITIVE SITUATION AND TRENDS 195
11.5.1 ACQUISITIONS 195
11.5.2 PRODUCT LAUNCHES 196
11.5.3 AGREEMENTS, PARTNERSHIPS, AND COLLABORATIONS 196
11.5.4 EXPANSIONS 197
12 COMPANY PROFILES 198
(Introduction, Products & Services, Strategy, & Analyst Insights, Developments, MnM View)*
12.1 BOEHRINGER INGELHEIM 198
12.2 ZOETIS 201
12.3 ELANCO 204
12.4 MERCK ANIMAL HEALTH 207
12.5 BAYER 210
12.6 VETOQUINOL 213
12.7 NORBROOK LABORATORIES 215
12.8 CEVA SANTÉ ANIMALE 217
12.9 DECHRA PHARMACEUTICALS 220
12.10 CHANELLE 223
12.11 K-LASER USA 224
12.12 ASSISI ANIMAL HEALTH 225

*Details on MarketsandMarkets view, Introduction, Product & Services, Strategy, & Analyst Insights, New Developments might not be captured in case of unlisted companies.
13 APPENDIX 226
13.1 INSIGHTS OF INDUSTRY EXPERTS 226
13.2 DISCUSSION GUIDE 227
13.3 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 231
13.4 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE 233
13.5 AVAILABLE CUSTOMIZATIONS 235
13.6 RELATED REPORTS 236
13.7 AUTHOR DETAILS 237

渋谷データカウント

渋谷データカウントは、最も信頼性が高く最新の調査分析レポートを確実に提供する経験豊富な調査専門家のグローバルチームが提供する、さまざまな業界のさまざまな市場調査レポートを提供する再販代理店です。

Recommended reports

+